They have three trials plus the two canceled in China

They have three trials plus the two canceled in China ):

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Open Label

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
Open Label

Expanded Access Remdesivir (RDV; GS-5734™)
Expanded access

No randomized with quadruple masking studies like us.

Some are more "equal" than others